Post-approval studies (Phase 4)UnknownNCT01911156
What this trial is testing
Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues
Who this might be right for
Chronic Hepatitis B
University Health Network, Toronto 66